Acute lymphocytic leukemia

Apr 14, 2020

AVM Biotechnology has FDA Approval for Clinical Trials for Promising New Cancer Treatment

Dec 09, 2019

Syndax Announces Preclinical Results Supporting Development of its Portfolio of Menin Inhibitors In Mixed Lineage Leukemias

Aug 06, 2019

Jazz Pharmaceuticals Advances Recombinant Crisantaspase Development Program

Sep 04, 2018

Medicine X Launches Story To Educate Cancer Patients

Apr 06, 2018

BESPONSA(TM) Approved by Health Canada for the Treatment of Adults with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia

Jan 31, 2018

T Cell Therapy Shows Persistent Benefits in Young Leukemia Patients

Dec 04, 2017

Final Results of the Phase I/II Clinical Study of BST-236 in Acute Leukemia Patients will be Presented at the 2017 Annual ASH Meeting

Nov 01, 2017

Jazz Pharmaceuticals to Highlight Hematology Research at ASH 2017 Annual Meeting

Oct 18, 2017

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Worth $3.4 Billion By 2025: Grand View Research, Inc.

Aug 17, 2017

FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

Jul 27, 2017

Seattle Children's Opens CD22 CAR T-Cell Immunotherapy Trial for Children and Young Adults Whose Leukemia Escapes CD19 CAR T-Cell Therapy

Jun 23, 2017

European Hematology Association: Delayed Exposure to Common Infections Causes Acute Leukemia of Childhood